首页> 外国专利> procedures for determination of dna in a sample of patients mulationen

procedures for determination of dna in a sample of patients mulationen

机译:小鼠血浆中dna的测定方法

摘要

A hierarchy of at least two assay techniques is utilized in testing for disease-associated mutations. The first assay in the hierarchy is selected to provide a highly specific test for the existence of the disease-associated mutation, although the accuracy of the test need not be high. The final assay in the hierarchy is selected to provide a highly accurate and highly specific test for the existence of the disease associated mutation. Intermediate tests of progressively greater accuracy may also be included in the hierarchy. Once the hierarchy has been selected for a given mutation-associated disease, a patient sample is analyzed the patient sample using the first, lowest accuracy assay in the hierarchy. If the result of the first assay is negative for the presence of a disease-associated mutation, then the next assay in the hierarchy is performed. This process is repeated until the final assay has been performed on all samples which gave negative results when tested by all less-accurate assays in the hierarchy. The test may be used for diagnosis and targeted screening for p53 mutations and mutations in the RB1 gene.
机译:至少两种测定技术的等级用于测试与疾病相关的突变。选择层次结构中的第一个检测方法,以提供针对疾病相关突变的高度特异性检测,尽管检测的准确性不需要很高。选择层次结构中的最终测定法以提供针对疾病相关突变的存在的高度准确和高度特异性的测试。逐渐提高的准确性的中间测试也可以包括在层次结构中。一旦为给定的突变相关疾病选择了层次结构,就使用层次结构中的第一个最低精度的分析方法对患者样品进行分析。如果对于与疾病相关的突变的存在,第一个测定的结果为阴性,则执行层次结构中的下一个测定。重复该过程,直到对所有样品进行了最终测定,当通过层次结构中所有较不精确的测定进行测试时,得出的结果均为阴性。该测试可用于诊断和针对性筛选p53突变和RB1基因中的突变。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号